Concord Drugs reports consolidated net loss of Rs 0.24 crore in the December 2023 quarter
Sales decline 5.54% to Rs 12.78 crore
Net loss of Concord Drugs reported to Rs 0.24 crore in the quarter ended December 2023 as against net profit of Rs 0.45 crore during the previous quarter ended December 2022. Sales declined 5.54% to Rs 12.78 crore in the quarter ended December 2023 as against Rs 13.53 crore during the previous quarter ended December 2022. ParticularsQuarter EndedDec. 2023Dec. 2022% Var.Sales12.7813.53 -6 OPM %4.9310.64 -PBDT0.131.00 -87 PBT-0.260.62 PL NP-0.240.45 PLPowered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content